BEAR: A Novel Virtual Screening Method Based on Large-Scale Bioactivity Data

COVID-19 drugs: potential interaction with ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein

Digestive enzyme supplementation in prescription drugs, over-the-counter drugs, and enzyme foods

Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers

Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia

Development and evaluation of a digestive formulation using a microbial enzyme for treatment of dyspepsia

Discovery of (E)-3-(3-((2-Cyano-4' -dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis

Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease

Drug-like small molecule HSP27 functional inhibitor sensitizes lung cancer cells to gefitinib or cisplatin by inducing altered cross-linked Hsp27 dimers

r sensitizes lung cancer cells to gefitinib or cisplatin by inducing altered cross-linked Hsp27 dimers